The Discounted Cash Flow (DCF) valuation of Repligen Corp (RGEN) is (6.24) USD. With the latest stock price at 126.96 USD, the upside of Repligen Corp based on DCF is -104.9%.
Based on the latest price of 126.96 USD and our DCF valuation, Repligen Corp (RGEN) is a sell. selling RGEN stocks now will result in a potential gain of 104.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.7% - 8.9% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (15.21) - (3.64) | (6.24) |
| Upside | -112.0% - -102.9% | -104.9% |